Pancreatic cancer clinical trials
1,153 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all pancreatic cancer studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting pancreatic cancer studies. A study counts once in each state where it has a site.
- Texas177
- California169
- New York130
- Florida121
- Massachusetts96
- Pennsylvania87
- Ohio86
- Tennessee86
- Michigan77
- Maryland76
- Virginia74
- Minnesota69
Also in China (336), France (116), Italy (91), Canada (77), Spain (73), United Kingdom (66), Australia (63), South Korea (53).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 125
- Phase 1164
- Phase 1 / Phase 2153
- Phase 2187
- Phase 2 / Phase 320
- Phase 357
- Phase 413
- No phase (devices, programs)234
- Observational300
Recently updated studies
Recruiting pancreatic cancer studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingObservationalNCT05052671
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Ages 18 Years – 99 Years · Oklahoma City, Oklahoma · Tulsa, Oklahoma · University of Oklahoma
- RecruitingPhase 1 / Phase 2NCT06914128
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Ages 18 Years and over · Birmingham, Alabama · Duarte, California +54 more · Bayer
- RecruitingPhase 1NCT07898683
A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer
Ages 18 Years – 75 Years · Obninsk, Russia · National Medical Research Radiological Centre of the Ministry of Health of Russia
- RecruitingPhase 2 / Phase 3NCT06943755
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ages 18 Years and over · Birmingham, Alabama · Phoenix, Arizona +114 more · Exelixis
- RecruitingPhase 1NCT07213791
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ages 18 Years and over · Newport Beach, California · Stanford, California +24 more · Eli Lilly and Company
- RecruitingPhase 1NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
Ages 18 Years and over · Houston, Texas · ParVation Therapeutics, Inc.
- RecruitingNo phase (devices, programs)NCT07605819
Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
Ages 20 Years and over · Nagakute, Aichi-ken · Nagoya, Aichi-ken +40 more · Cosomil, Inc.
- RecruitingNo phase (devices, programs)NCT05334836
Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features
Ages 18 Years and over · Shatin, New Territories · Chinese University of Hong Kong
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.